Morris Jagodowicz
Anesthesiology · Northridge, CANPI 1184699308
Payments from drug & device makers
Across 287 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Biohaven Pharmaceuticals, Inc.$1K
- Indivior Inc.$955
- Teva Pharmaceuticals USA, Inc.$568
- Amgen$557
- Merz North America, Inc.$289
- plus $1K from 26 others
What the payments were for
- Consulting fees$1,20018%
- Travel & lodging$651%
- Food & beverage$5,58181%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 105 | $1,754 |
| Biohaven Pharmaceuticals, Inc. | 6 | $1,348 |
| Indivior Inc. | 32 | $955 |
| Teva Pharmaceuticals USA, Inc. | 40 | $568 |
| Amgen(2 entities) | 28 | $557 |
| Merz North America, Inc. | 2 | $289 |
| Pfizer | 10 | $187 |
| AstraZeneca | 2 | $149 |
| Zyla Life Sciences, Inc. | 18 | $145 |
| Sanofi | 4 | $103 |
| Hikma Pharmaceuticals USA | 6 | $100 |
| Lilly USA, LLC | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 1 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Abbott | 2 | $47 |
| GSK | 2 | $39 |
| Kaleo, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Biodelivery Sciences International, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $31 |
| Alkermes, Inc. | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 3 | $24 |
| Forte Bio-pharma LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- AUSTEDO$264
- SUBLOCADE$243
- XEOMIN$200
- FASENRA$126
How this compares
$6,850 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 13 | $7,513 |
| Buprenorphine Hcl | 30 | $713 |
| Eszopiclone | 11 | $417 |
| Pregabalin | 35 | $389 |
| Methadone Hcl | 11 | $302 |
| Ibuprofen | 32 | $188 |
| Trazodone Hcl | 13 | $185 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $96 |
| Ondansetron OdtOndansetron | 16 | $48 |
| Alprazolam | 21 | $44 |
| RizatriptanRizatriptan Benzoate | 11 | $37 |
| Diazepam | 15 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,754 | $7,51313 claims |
| Hikma Pharmaceuticals USABuprenorphine Hcl | $100 | $71330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,717 anesthesiology providers in California.
Other anesthesiology in Northridge
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
- Joseph AntogniniSacramento$1.4M
- Daniel NguyenDuarte$1.4M
- Jack JengSouth San Francisco$1.3M
- Eilon GabelLos Angeles$1.2M
- Philip BicklerSan Francisco$853K
- Joseph RinehartNewport Beach$824K
- Richard Applegate IiLoma Linda$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.